目的探讨改良超长降调节方案绒毛膜性腺激素(HCG)日血清黄体生成素(LH)水平与多囊卵巢综合症(PCOS)不孕患者体外受精/卵胞浆内单精子显微注射-胚胎移植技术(IVF/ICSI-ET)结果的关系。方法方便选取2013年6月—2016年2月在郑州大学附属洛...目的探讨改良超长降调节方案绒毛膜性腺激素(HCG)日血清黄体生成素(LH)水平与多囊卵巢综合症(PCOS)不孕患者体外受精/卵胞浆内单精子显微注射-胚胎移植技术(IVF/ICSI-ET)结果的关系。方法方便选取2013年6月—2016年2月在郑州大学附属洛阳中心医院采用改良超长方案的PCOS患者200例,所有患者促排卵启动日LH>0.5 m IU/m L。按照扳机日LH水平分为A、B两组。A组150例,LH>0.5 m IU/m L;B组50例,LH≤0.5 m IU/m L。比较各组取卵数、优胚率、胚胎种植率、临床妊娠率、流产率。结果取卵数各组间差异无统计学意义(P>0.05);A组与B组比较,优胚率(69.4%VS 60.7%)、胚胎种植率(40.8%VS 36.9%)、临床妊娠率(62.0%VS 46.0%),差异均有统计学意义(P<0.05);流产率A组为4.3%,低于B组的17.4%,差异有统计学意义(P<0.05)。结论改良超长方案PCOS患者HCG日适当的LH水平有助于改善临床结局,LH<0.5m IU/ml可取消胚胎移植。展开更多
Background The successful end-point of in vitro fertilization （IVF） treatment is for a woman to give live birth. This outcome is based on various factors including adequate number of retrieved eggs. Failure to recru...Background The successful end-point of in vitro fertilization （IVF） treatment is for a woman to give live birth. This outcome is based on various factors including adequate number of retrieved eggs. Failure to recruit adequate follicles, from which the eggs are retrieved, is called a ＂poor response＂. How to improve the clinical pregnancy rates of poor responders was one of the tough problems for IVF. Methods The study involved 51 patients who responded poorly to high dose gonadotropin treatment in their previous cycles at our reproductive center, between April 2010 and February 2012. The previous cycle （group A） received routine long protocol; the subsequent cycle （group B） received modified super-long down-regulation protocol. The primary outcome of the study was the number of oocytes fertilized. The increase in the pregnancy rate was the secondary outcome. Differences between the groups were assessed by using Student＇s t test and Z2 test where appropriate. Results The patients＇ average age was （36.64±3.85） years. The mean duration of ovarian stimulation cycles of the group A patients was longer than those of the group B patients. The total dose of follicle-stimulating hormone （FSH） was significantly lower in the subsequent cycle. The peak value of serum estradiol on human chorionic gonadotrophin （hCG） day was lower in group A as compared with group B. The number of metaphase II oocytes recovered was significantly higher in group B. The cleavage rate in group A was significantly lower than in group B, 49 patients in group B reached embryo transfer stage, while 46 patients in group A reached this stage. Patients in group B received significantly more embryos per transfer as compared with group A. More pregnancies and more clinical pregnancies with fetal heart activity were achieved in group B. Conclusions This comparative trial shows that poor responder women undergoing repeated assisted reproduction treatment using modified super-long down-regulation protocol achieve more oocytes展开更多
文摘目的探讨改良超长降调节方案绒毛膜性腺激素(HCG)日血清黄体生成素(LH)水平与多囊卵巢综合症(PCOS)不孕患者体外受精/卵胞浆内单精子显微注射-胚胎移植技术(IVF/ICSI-ET)结果的关系。方法方便选取2013年6月—2016年2月在郑州大学附属洛阳中心医院采用改良超长方案的PCOS患者200例,所有患者促排卵启动日LH>0.5 m IU/m L。按照扳机日LH水平分为A、B两组。A组150例,LH>0.5 m IU/m L;B组50例,LH≤0.5 m IU/m L。比较各组取卵数、优胚率、胚胎种植率、临床妊娠率、流产率。结果取卵数各组间差异无统计学意义(P>0.05);A组与B组比较,优胚率(69.4%VS 60.7%)、胚胎种植率(40.8%VS 36.9%)、临床妊娠率(62.0%VS 46.0%),差异均有统计学意义(P<0.05);流产率A组为4.3%,低于B组的17.4%,差异有统计学意义(P<0.05)。结论改良超长方案PCOS患者HCG日适当的LH水平有助于改善临床结局,LH<0.5m IU/ml可取消胚胎移植。
文摘Background The successful end-point of in vitro fertilization （IVF） treatment is for a woman to give live birth. This outcome is based on various factors including adequate number of retrieved eggs. Failure to recruit adequate follicles, from which the eggs are retrieved, is called a ＂poor response＂. How to improve the clinical pregnancy rates of poor responders was one of the tough problems for IVF. Methods The study involved 51 patients who responded poorly to high dose gonadotropin treatment in their previous cycles at our reproductive center, between April 2010 and February 2012. The previous cycle （group A） received routine long protocol; the subsequent cycle （group B） received modified super-long down-regulation protocol. The primary outcome of the study was the number of oocytes fertilized. The increase in the pregnancy rate was the secondary outcome. Differences between the groups were assessed by using Student＇s t test and Z2 test where appropriate. Results The patients＇ average age was （36.64±3.85） years. The mean duration of ovarian stimulation cycles of the group A patients was longer than those of the group B patients. The total dose of follicle-stimulating hormone （FSH） was significantly lower in the subsequent cycle. The peak value of serum estradiol on human chorionic gonadotrophin （hCG） day was lower in group A as compared with group B. The number of metaphase II oocytes recovered was significantly higher in group B. The cleavage rate in group A was significantly lower than in group B, 49 patients in group B reached embryo transfer stage, while 46 patients in group A reached this stage. Patients in group B received significantly more embryos per transfer as compared with group A. More pregnancies and more clinical pregnancies with fetal heart activity were achieved in group B. Conclusions This comparative trial shows that poor responder women undergoing repeated assisted reproduction treatment using modified super-long down-regulation protocol achieve more oocytes
